TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,060,114 | -59.2% | 123,193 | -75.3% | 0.01% | -58.6% |
Q1 2023 | $7,494,297 | +148.0% | 498,291 | +95.1% | 0.03% | +163.6% |
Q4 2022 | $3,021,962 | +71.4% | 255,449 | -14.2% | 0.01% | +83.3% |
Q3 2022 | $1,763,000 | +79.9% | 297,843 | +29.1% | 0.01% | +50.0% |
Q2 2022 | $980,000 | -43.9% | 230,690 | +25.5% | 0.00% | -33.3% |
Q1 2022 | $1,748,000 | +34.7% | 183,793 | +169.1% | 0.01% | +20.0% |
Q4 2021 | $1,298,000 | +42.6% | 68,309 | +150.0% | 0.01% | +25.0% |
Q3 2021 | $910,000 | +27.1% | 27,329 | +48.1% | 0.00% | +33.3% |
Q2 2021 | $716,000 | – | 18,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |